Mostrar el registro sencillo del ítem

dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.contributor.authorBermudez, Valmore
dc.contributor.authorRojas, Joselyn
dc.contributor.authorSalazar, Juan
dc.contributor.authorMartinez, Maria Sofia
dc.contributor.authorOlivar, Luis
dc.contributor.authorCalvo, Maria Jose
dc.contributor.authorMindiola, Andres
dc.contributor.authorAñez, Roberto
dc.contributor.authorWilches-Duran, Sandra
dc.contributor.authorCerda, Marcos
dc.contributor.authorGraterol, Modesto
dc.contributor.authorGraterol, Rosemily
dc.contributor.authorHernandez, Juan Diego
dc.contributor.authorGaricano, Carlos
dc.contributor.authorVelasco, Manuel
dc.date.accessioned2018-07-12T20:15:19Z
dc.date.available2018-07-12T20:15:19Z
dc.date.issued2018-02
dc.identifier.issn20461402
dc.identifier.urihttp://hdl.handle.net/20.500.12442/2176
dc.description.abstractBackground: In 1980, Reuben Andresen observed that in certain individuals, obesity did not increase mortality, introducing an atypical phenotype called “healthy obese”. Other studies reported that 10-15 % of lean individuals presented insulin resistance, hyperglycemia and dyslipidemia. The objective of this study was to evaluate biochemical and clinical characteristics of metabolic phenotypes in Maracaibo city. Methods: A descriptive, cross-sectional study with a randomized multistage sampling was performed including 1226 non diabetic individuals from both sexes. For phenotype definition, the subjects were first classified according to their BMI into Normal-Weight, Overweight and Obese; then divided in metabolically healthy and unhealthy using a two-step analysis cluster. To evaluate the relationship with coronary risk, a multiple logistic regression model was performed. Results: In the studied population, 5.2% (n=64) corresponded to unhealthy lean subjects, and 17.4% (n=217) to healthy obese subjects. Metabolically unhealthy normal-weight (MUNW) phenotype was found in males in 53.3% in contrast to 51.3% of metabolically unhealthy obese (MUO) phenotype found in females. An association between metabolically unhealthy phenotypes and a higher risk of a coronary event was found, especially for obese individuals (MHO: OR=1.85 CI95%: 1.11-3.09; p=0.02 and MUO: OR=2.09 CI95%: 1.34-3.28; p<0.01). Conclusion: Individuals with atypical metabolic phenotypes exist in Maracaibo city. Related factors may include insulin resistance, basal glucose levels, and triglycerides levels. Lastly, cardiovascular risk exhibited by healthy obese individuals should be classified in categories of major coronary risk related to lean subjects.eng
dc.language.isoengeng
dc.publisheris published by F1000 Research Ltdeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceF1000Researcheng
dc.sourceVol. 7, No.230 (2018)spa
dc.source.urihttps://f1000research.com/articles/7-230/v1eng
dc.subjectMetabolic phenotypeseng
dc.subjecttwo-step clustereng
dc.subjectMetabolically unhealthy leaneng
dc.subjectMetabolically healthy obeseeng
dc.subjectCoronary riskeng
dc.titleBiochemical and clinical characterization of metabolic phenotypes: a cross-sectional study from Maracaibo city, Venezuela [version 1; referees: awaiting peer review]eng
dc.typeArticleeng
dcterms.bibliographicCitationWorld Health Organization (WHO): Obesity and overweight: Fact Sheet. 2016; [cited 2017 Mar 20].eng
dcterms.bibliographicCitationCenter for Disease Control and Prevention (CDC): Adult Obesity Causes & Consequences | Overweight & Obesity. 2016; [cited 2017 Mar 20].eng
dcterms.bibliographicCitationAndres R: Effect of obesity on total mortality. Int J Obes. 1980; 4(4): 381–6.eng
dcterms.bibliographicCitationFerrannini E, Natali A, Bell P, et al.: Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 1997; 100(5): 1166–73.eng
dcterms.bibliographicCitationBernstein RS, Grant N, Kipnis DM: Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without obesity or diabetes mellitus. Diabetes. 1975; 24(2): 207–13.eng
dcterms.bibliographicCitationRuderman NB, Schneider SH, Berchtold P: The “metabolically-obese,” normalweight individual. Am J Clin Nutr. 1981; 34(8): 1617–21.eng
dcterms.bibliographicCitationShaharyar S, Roberson LL, Jamal O, et al.: Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population. J Obes. 2015; 2015: 178526.eng
dcterms.bibliographicCitationBermúdez V, Marcano RP, Cano C, et al.: The Maracaibo city metabolic syndrome prevalence study: design and scope. Am J Ther. 2010; 17(3): 288–94.eng
dcterms.bibliographicCitationBermúdez V, Rojas J, Salazar J, et al.: Sensitivity and Specificity Improvement in Abdominal Obesity Diagnosis Using Cluster Analysis during Waist Circumference Cut-Off Point Selection. J Diabetes Res. 2015; 2015: 750265.eng
dcterms.bibliographicCitationMendez Castellano H, de Mendez MC: Estratificacion social y biologia humana: metodo Graffar modificado. Arch Venez Pueric Pediatría. 1986; 49(3–4): 93–104.eng
dcterms.bibliographicCitationChobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19): 2560–72.eng
dcterms.bibliographicCitationWorld Health Organization (WHO): The world health report 2003 - shaping the future. 2003; [cited 2017 Nov 20].eng
dcterms.bibliographicCitationCenter for Disease Control and Prevention (CDC): Health Statistics, NHANES III Reference Manuals and Reports. 1996; [cited 2017 Nov 20].eng
dcterms.bibliographicCitationBermudez V, Salazar J, Martínez MS, et al.: Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela. Adv Prev Med. 2016; 2016: 9405105.eng
dcterms.bibliographicCitationFriedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6): 499–502.eng
dcterms.bibliographicCitationLevy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998; 21(12): 2191–2.eng
dcterms.bibliographicCitationAmato MC, Giordano C, Galia M, et al.: Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33(4): 920–2.eng
dcterms.bibliographicCitationAlberti KG, Eckel RH, Grundy SM, et al.: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640–5.eng
dcterms.bibliographicCitationBermúdez V, Salazar J, Bello L, et al.: Coronary Risk Estimation According to a Recalibrated Framingham-Wilson Score in the Maracaibo City Metabolic Syndrome Prevalence Study. J Cardiol Photon. 2014; 107: 160–8.eng
dcterms.bibliographicCitationWorld Health Organization (WHO): Global action plan for the prevention and control of NCDs 2013–2020. 2013; [cited 2017 Nov 20].eng
dcterms.bibliographicCitationHubert HB, Feinleib M, McNamara PM, et al.: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5): 968–77.eng
dcterms.bibliographicCitationBrochu M, Tchernof A, Dionne IJ, et al.: What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001; 86(3): 1020–5.eng
dcterms.bibliographicCitationStefan N, Kantartzis K, Machann J, et al.: Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008; 168(15): 1609–16.eng
dcterms.bibliographicCitationAguilar-Salinas CA, García EG, Robles L, et al.: High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab. 2008; 93(10): 4075–9.eng
dcterms.bibliographicCitationMartínez-Larrad MT, Corbatón Anchuelo A, Del Prado N, et al.: Profile of individuals who are metabolically healthy obese using different definition criteria. A population-based analysis in the spanish population. PLoS One. 2014; 9(9): e106641.eng
dcterms.bibliographicCitationLee K: Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr. 2009; 18(2): 280–4.eng
dcterms.bibliographicCitationZheng R, Yang M, Bao Y, et al.: Prevalence and Determinants of Metabolic Health in Subjects with Obesity in Chinese Population. Int J Environ Res Public Health. 2015; 12(11): 13662–77.eng
dcterms.bibliographicCitationCalori G, Lattuada G, Piemonti L, et al.: Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care. 2011; 34(1): 210–5.eng
dcterms.bibliographicCitationLopez-Garcia E, Guallar-Castillon P, Leon-Muñoz L, et al.: Prevalence and determinants of metabolically healthy obesity in Spain. Atherosclerosis. 2013; 231(1): 152–7.eng
dcterms.bibliographicCitationHamer M, Bell JA, Sabia S, et al.: Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur J Endocrinol. 2015; 173(5): 703–8.eng
dcterms.bibliographicCitationKuk JL, Ardern CI: Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009; 32(12): 2297–9.eng
dcterms.bibliographicCitationWildman RP, Muntner P, Reynolds K, et al.: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008; 168(15): 1617–24.eng
dcterms.bibliographicCitationFanghänel-Salmón G, Gutiérrez-Salmeán G, Samaniego V, et al.: Obesity Phenotypes In Urban Middle-Class Cohorts; The Prit-Lindavista Merging Evidence In Mexico: The Opus Prime Study. Nutr Hosp. 2015; 32(1): 182–8.eng
dcterms.bibliographicCitationBo S, Musso G, Gambino R, et al.: Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a populationbased cohort. Am J Clin Nutr. 2012; 96(5): 962–9.eng
dcterms.bibliographicCitationHinnouho GM, Czernichow S, Dugravot A, et al.: Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J. 2015; 36(9): 551–9.eng
dcterms.bibliographicCitationYoo HK, Choi EY, Park EW, et al.: Comparison of Metabolic Characteristics of Metabolically Healthy but Obese (MHO) Middle-Aged Men According to Different Criteria. Korean J Fam Med. 2013; 34(1): 19–26.eng
dcterms.bibliographicCitationSchmiegelow MD, Hedlin H, Mackey RH, et al.: Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women. J Am Heart Assoc. 2015; 4(5): pii:e001695.eng
dcterms.bibliographicCitationYang HK, Han K, Kwon HS, et al.: Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea. Sci Rep. 2016; 6(6): 30329.eng
dcterms.bibliographicCitationDiniz Mde F, Beleigoli AM, Ribeiro AL, et al.: Factors associated with metabolically healthy status in obesity, overweight, and normal weight at baseline of ELSA-Brasil. Medicine (Baltimore). 2016; 95(27): e4010.eng
dcterms.bibliographicCitationOrtega FB, Lee DC, Katzmarzyk PT, et al.: The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J. 2013; 34(5): 389–97.eng
dcterms.bibliographicCitationRomero-Corral A, Somers VK, Sierra-Johnson J, et al.: Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010; 31(6): 737–46.eng
dcterms.bibliographicCitationMadeira FB, Silva AA, Veloso HF, et al.: Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS One. 2013; 8(3): e60673.eng
dcterms.bibliographicCitationSuccurro E, Marini MA, Frontoni S, et al.: Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obes (Silver Spring). 2008; 16(8): 1881–6.eng
dcterms.bibliographicCitationOgorodnikova AD, Kim M, McGinn AP, et al.: Incident cardiovascular disease events in metabolically benign obese individuals. Obes (Silver Spring). 2012; 20(3): 651–9.eng
dcterms.bibliographicCitationHansen L, Netterstrøm MK, Johansen NB, et al.: Metabolically Healthy Obesity and Ischemic Heart Disease: A 10-Year Follow-Up of the Inter99 Study. J Clin Endocrinol Metab. 2017; 102(6): 1934–1942.eng
dcterms.bibliographicCitationKim NH, Seo JA, Cho H, et al.: Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study. Medicine (Baltimore). 2016; 95(15): e3384.eng
dcterms.bibliographicCitationDurward CM, Hartman TJ, Nickols-Richardson SM: All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes. 2012; 2012: 460321.eng
dcterms.bibliographicCitationShaharyar S, Roberson LL, Jamal O, et al.: Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population. J Obes. 2015; 2015: 178526.eng
dcterms.bibliographicCitationKhan UI, Wang D, Thurston RC, et al.: Burden of subclinical cardiovascular disease in “metabolically benign” and “at-risk” overweight and obese women: the Study of Women’s Health Across the Nation (SWAN). Atherosclerosis. 2011; 217(1): 179–86.eng
dcterms.bibliographicCitationBermudez V, Rojas J, Salazar J, et al.: Dataset 1 in: Biochemical and clinical characterization of metabolic phenotypes: a cross-sectional study from Maracaibo city, Venezuela. F1000Research. 2018.eng


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem